Development of etoricoxib-loaded mesoporous silica nanoparticles laden gel as vehicle for transdermal delivery: optimization, ex vivo permeation, histopathology, and in vivo anti-inflammatory study
Authors:
- 11 April 2025
- journal article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 51 (5) , 506-521
Abstract
Etoricoxib (ETB) is a nonsteroidal anti-inflammatory therapeutic agent. It is poorly soluble and has various gastrointestinal side effects such as bleeding and ulcers after oral administration. The present research aimed to develop an ETB-loaded mesoporous silica nanoparticle-laden gel (ETB-MSNPs) for transdermal delivery to improve therapeutic efficacy. The ETB-MSNPs were synthesized using a precipitation and solvent evaporation technique and their optimization was performed using a Box-Behnken design. The optimized ETB-MSNPs were incorporated into a carbopol-chitosan gel and evaluated for in-vitro, ex-vivo, and in-vivo anti-inflammatory activity. The ETB-MSNPs displayed nanosize of particles with nanosize distribution and high entrapment efficiency of ETB. The FTIR and DSC studies showed that ETB was encapsulated in MSNPs. The optimized ETB-MSNPs were successfully integrated into the carbopol and chitosan gel, which exhibited excellent viscosity and spreadability. The optimized ETB-MSNPs gel exhibited a significantly higher and more sustained release of ETB compared to pure ETB gel. Optimized ETB-MSNPs gel exhibited a considerably higher anti-inflammatory effect with a significant reduction in IL-1β and TNF-α levels compared to pure ETB gel. The histopathological examination confirmed that optimized ETB-MSNPs gel did not exhibit any toxicity on the skin. Based on the findings, the results suggest that the MSNPs gel has the potential as a carrier for enhancing the therapeutic efficacy of ETB through topical delivery, although further studies are needed to fully confirm its effectiveness.Keywords
This publication has 34 references indexed in Scilit:
- Development, optimization, and characterization of polymeric micelles to improve dasatinib oral bioavailability: Hep G2 cell cytotoxicity and in vivo pharmacokinetics for targeted liver cancer therapyHeliyon, 2024
- Colchicine mesoporous silica nanoparticles/hydrogel composite loaded cotton patches as a new encapsulator system for transdermal osteoarthritis managementInternational Journal of Biological Macromolecules, 2020
- Mesoporous silica nanoparticles: facile surface functionalization and versatile biomedical applications in oncologyActa Biomaterialia, 2020
- Understanding the role of solvent properties on reaction kinetics for synthesis of silica nanoparticlesChemical Engineering Journal, 2020
- Etoricoxib treatment prevented body weight gain and ameliorated oxidative stress in the liver of high-fat diet–fed ratsNaunyn-Schmiedeberg's Archives of Pharmacology, 2020
- Particle size control of monodispersed spherical nanoparticles with MCM-48-type mesostructure via novel rapid synthesis procedureJournal of Nanoparticle Research, 2019
- Vicinal Diaryl Heterocyclic System: A Privileged Scaffold in the Discovery of Potential Therapeutic Agents2018
- Use of mesoporous cellular foam (MCF) in preparation of polymeric microspheres for long acting injectable release formulations of paliperidone antipsychotic drugEuropean Journal of Pharmaceutics and Biopharmaceutics, 2017
- Synthesis of mesoporous silica nanoparticles by sol–gel as nanocontainer for future drug delivery applicationsBoletín de la Sociedad Española de Cerámica y Vidrio, 2017
- Effect of particle morphology and pore size on the release kinetics of ephedrine from mesoporous MCM-41 materialsJournal of Porous Materials, 2011